Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP866358.RAVxNmD7eHl1PpXM6v1sGMi41RNUczI7CJj1_HGyQG5Yk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP866358.RAVxNmD7eHl1PpXM6v1sGMi41RNUczI7CJj1_HGyQG5Yk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP866358.RAVxNmD7eHl1PpXM6v1sGMi41RNUczI7CJj1_HGyQG5Yk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP866358.RAVxNmD7eHl1PpXM6v1sGMi41RNUczI7CJj1_HGyQG5Yk130_provenance.
- NP866358.RAVxNmD7eHl1PpXM6v1sGMi41RNUczI7CJj1_HGyQG5Yk130_assertion description "[Ecallantide is a potent and specific plasma kallikrein inhibitor approved for the treatment of acute attacks of HAE affecting any anatomic site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866358.RAVxNmD7eHl1PpXM6v1sGMi41RNUczI7CJj1_HGyQG5Yk130_provenance.
- NP866358.RAVxNmD7eHl1PpXM6v1sGMi41RNUczI7CJj1_HGyQG5Yk130_assertion evidence source_evidence_literature NP866358.RAVxNmD7eHl1PpXM6v1sGMi41RNUczI7CJj1_HGyQG5Yk130_provenance.
- NP866358.RAVxNmD7eHl1PpXM6v1sGMi41RNUczI7CJj1_HGyQG5Yk130_assertion SIO_000772 22149337 NP866358.RAVxNmD7eHl1PpXM6v1sGMi41RNUczI7CJj1_HGyQG5Yk130_provenance.
- NP866358.RAVxNmD7eHl1PpXM6v1sGMi41RNUczI7CJj1_HGyQG5Yk130_assertion wasDerivedFrom befree-20140225 NP866358.RAVxNmD7eHl1PpXM6v1sGMi41RNUczI7CJj1_HGyQG5Yk130_provenance.
- NP866358.RAVxNmD7eHl1PpXM6v1sGMi41RNUczI7CJj1_HGyQG5Yk130_assertion wasGeneratedBy ECO_0000203 NP866358.RAVxNmD7eHl1PpXM6v1sGMi41RNUczI7CJj1_HGyQG5Yk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP866358.RAVxNmD7eHl1PpXM6v1sGMi41RNUczI7CJj1_HGyQG5Yk130_provenance.